|
JP2647427B2
(ja)
|
1987-04-24 |
1997-08-27 |
帝人株式会社 |
被検者の病態の判定のための検出方法、モノクロ−ナル抗体および検出キット
|
|
DE68927933T2
(de)
|
1988-09-02 |
1997-08-14 |
Dyax Corp |
Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US4908372A
(en)
|
1988-10-13 |
1990-03-13 |
Merrell Dow Pharmaceuticals Inc. |
Antihistaminic piperidinyl benzimidazoles
|
|
DE3843534A1
(de)
|
1988-12-23 |
1990-07-12 |
Basf Ag |
Neue tnf-polypeptide
|
|
US6498237B2
(en)
|
1989-08-07 |
2002-12-24 |
Peptech Limited |
Tumor necrosis factor antibodies
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
WO1991010737A1
(en)
|
1990-01-11 |
1991-07-25 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
WO1992002551A1
(en)
|
1990-08-02 |
1992-02-20 |
B.R. Centre Limited |
Methods for the production of proteins with a desired function
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
WO1992003918A1
(en)
|
1990-08-29 |
1992-03-19 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
DK0564531T3
(da)
|
1990-12-03 |
1998-09-28 |
Genentech Inc |
Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber
|
|
GB9028123D0
(en)
|
1990-12-28 |
1991-02-13 |
Erba Carlo Spa |
Monoclonal antibodies against human tumor necrosis factor alpha
|
|
DK1471142T3
(da)
|
1991-04-10 |
2009-03-09 |
Scripps Research Inst |
Heterodimere receptor-biblioteker under anvendelse af fagemider
|
|
GB9113120D0
(en)
|
1991-06-18 |
1991-08-07 |
Kodak Ltd |
Photographic processing apparatus
|
|
IT1249708B
(it)
|
1991-09-23 |
1995-03-09 |
Tecnogen Scpa |
Metodo per la determinazione del fattore di necrosi tumorale (tnf) in forma biologicamente attiva.
|
|
DE69233745D1
(de)
|
1991-12-02 |
2008-10-23 |
Cambridge Antibody Tech |
Herstellung von Autoantikörpern auf Phagenoberflächen ausgehend von Antikörpersegmentbibliotheken
|
|
AU3347493A
(en)
|
1992-01-09 |
1993-08-03 |
Janssen Pharmaceutica N.V. |
Pharmaceutically active substituted benzimidazole derivatives
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
WO1994018325A1
(en)
|
1993-02-03 |
1994-08-18 |
N.V. Innogenetics S.A. |
Tnf-alpha muteins and a process for preparing them
|
|
CA2119089A1
(en)
|
1993-03-29 |
1994-09-30 |
David Banner |
Tumor necrosis factor muteins
|
|
JPH09506262A
(ja)
|
1993-12-08 |
1997-06-24 |
ジェンザイム・コーポレイション |
特異的抗体の製造方法
|
|
DE69534347T2
(de)
|
1994-01-31 |
2006-05-24 |
Trustees Of Boston University, Boston |
Bibliotheken aus Polyklonalen Antikörpern
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
DE4440613C1
(de)
|
1994-11-14 |
1996-07-25 |
Leica Ag |
Vorrichtung und Verfahren zur Detektion und Demodulation eines intensitätsmodulierten Strahlungsfeldes
|
|
TW453995B
(en)
|
1995-12-15 |
2001-09-11 |
Novartis Ag |
Certain alpha-substituted arylsulfonamido acetohydroxamic acids
|
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
CN1204230A
(zh)
|
1997-12-08 |
1999-01-06 |
李建安 |
一种手提电话机用防护罩及其制做方法
|
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
|
GB9828628D0
(en)
*
|
1998-12-23 |
1999-02-17 |
Glaxo Group Ltd |
Novel ligand
|
|
US7101974B2
(en)
*
|
2000-03-02 |
2006-09-05 |
Xencor |
TNF-αvariants
|
|
EP1399435A2
(en)
|
2000-09-01 |
2004-03-24 |
Biogen, Inc. |
Pyridine derivatives useful as cd40:cd154 binding interruptors and use thereof to treat immunological complications
|
|
MXPA03011006A
(es)
|
2001-06-05 |
2004-02-27 |
Boehringer Ingelheim Pharma |
Compuestos de cicloalquil urea benzo-fusionados 1,4-disustituidos.
|
|
US6632810B2
(en)
|
2001-06-29 |
2003-10-14 |
Kowa Co., Ltd. |
Cyclic diamine compound with condensed-ring groups
|
|
JP2003040888A
(ja)
|
2001-07-30 |
2003-02-13 |
Sankyo Co Ltd |
イミダゾール誘導体
|
|
MXPA05001268A
(es)
|
2002-08-01 |
2005-10-06 |
Wyeth Corp |
Metodos y reactivos relacionados con la inflamacion y apoptosis.
|
|
CA2507004A1
(en)
|
2002-12-03 |
2004-06-17 |
Celltech R & D Limited |
Assay for identifying antibody producing cells
|
|
CA2524623A1
(en)
|
2003-05-09 |
2004-11-18 |
Pharmexa A/S |
Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
|
|
GB0312481D0
(en)
|
2003-05-30 |
2003-07-09 |
Celltech R&D Ltd |
Antibodies
|
|
GB0315457D0
(en)
|
2003-07-01 |
2003-08-06 |
Celltech R&D Ltd |
Biological products
|
|
GB0315450D0
(en)
|
2003-07-01 |
2003-08-06 |
Celltech R&D Ltd |
Biological products
|
|
CA2527020A1
(en)
|
2003-07-01 |
2005-01-13 |
Celltech R & D Limited |
Modified antibody fab fragments
|
|
CN102358903B
(zh)
|
2003-07-15 |
2017-04-26 |
安姆根有限公司 |
作为选择性ngf途径抑制剂的人抗ngf中和抗体
|
|
US7268116B2
(en)
|
2003-10-02 |
2007-09-11 |
Genhunter Corp. |
Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
|
|
TW200526780A
(en)
*
|
2004-01-06 |
2005-08-16 |
Hayashibara Biochem Lab |
TNF antagonists and TNF inhibitors comprising the same as the active ingredient
|
|
GB0411186D0
(en)
|
2004-05-19 |
2004-06-23 |
Celltech R&D Ltd |
Biological products
|
|
CN103254309B
(zh)
|
2005-05-18 |
2017-09-26 |
埃博灵克斯股份有限公司 |
针对肿瘤坏死因子α的改进的纳米体TM
|
|
DE102005023617A1
(de)
|
2005-05-21 |
2006-11-23 |
Aspre Ag |
Verfahren zum Mischen von Farben in einem Display
|
|
WO2007060411A1
(en)
|
2005-11-24 |
2007-05-31 |
Ucb Pharma S.A. |
Anti-tnf alpha antibodies which selectively inhibit tnf alpha signalling through the p55r
|
|
US9056905B2
(en)
*
|
2007-05-21 |
2015-06-16 |
Alderbio Holdings Llc |
Antibodies to TNF-α and use thereof
|
|
TWI501976B
(zh)
*
|
2007-05-21 |
2015-10-01 |
Alder Biopharmaceuticals Inc |
抗ＴＮＦ－α之抗體及其用途
|
|
AR067786A1
(es)
|
2007-08-03 |
2009-10-21 |
Alcon Mfg Ltd |
Inhibicion relacionada con arni (arn de interferencia) de senales tnfalfa (factor de necrosis tumoral) para el tratamiento de glaucoma
|
|
EP2195341B1
(en)
|
2007-09-26 |
2017-03-22 |
UCB Biopharma SPRL |
Dual specificity antibody fusions
|
|
US9365644B2
(en)
|
2008-04-23 |
2016-06-14 |
Epitomics, Inc. |
Anti-TNFα antibody
|
|
AU2009264564B2
(en)
|
2008-06-25 |
2014-05-08 |
Novartis Ag |
Stable and soluble antibodies inhibiting TNFalpha
|
|
WO2010058419A1
(en)
|
2008-11-20 |
2010-05-27 |
Panacea Biotec Ltd |
Tumor necrosis factor alpha inhibiting peptides and uses thereof
|
|
JP2010172307A
(ja)
|
2009-01-30 |
2010-08-12 |
Saitama Medical Univ |
関節リウマチに対する可溶性ＴＮＦα／ＬＴαレセプター薬の薬効予測方法、及び薬効予測装置
|
|
WO2010118404A2
(en)
|
2009-04-09 |
2010-10-14 |
California Institute Of Technology |
Methods for creating or identifying compounds that bind tumor necrosis factor alpha
|
|
JP5795759B2
(ja)
|
2009-04-16 |
2015-10-14 |
アッヴィ・バイオセラピューティクス・インコーポレイテッド |
抗ＴＮＦ−α抗体およびその用途
|
|
JP2013523153A
(ja)
|
2010-04-07 |
2013-06-17 |
アッヴィ・インコーポレイテッド |
ＴＮＦ−α結合タンパク質
|
|
US8377441B2
(en)
|
2010-08-03 |
2013-02-19 |
National Cheng Kung University |
Treating breast cancer with anti-IL-19 antibody
|
|
AU2011320140C1
(en)
|
2010-10-30 |
2019-12-12 |
Kindex Pharmaceuticals, Inc. |
Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(-3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
|
|
AR084210A1
(es)
|
2010-12-08 |
2013-05-02 |
Abbott Lab |
PROTEINAS DE UNION AL TNF-a
|
|
EP2721066A1
(en)
|
2011-06-17 |
2014-04-23 |
Glaxo Group Limited |
Tumour necrosis factor receptor 1 antagonists
|
|
WO2013024040A2
(en)
|
2011-08-12 |
2013-02-21 |
B.S.R.C. Alexander Fleming |
Tnf superfamily trimerization inhibitors
|
|
ES2675583T3
(es)
|
2012-06-11 |
2018-07-11 |
Ucb Biopharma Sprl |
Bencimidazoles moduladores de TNF-alfa
|
|
WO2014001557A1
(en)
*
|
2012-06-28 |
2014-01-03 |
Ucb Pharma S.A. |
A method for identifying compounds of therapeutic interest
|
|
BR112015000675B1
(pt)
|
2012-07-13 |
2022-07-12 |
UCB Biopharma SRL |
Derivados de imidazopiridina como moduladores da atividade de tnf
|
|
GB201212513D0
(en)
*
|
2012-07-13 |
2012-08-29 |
Ucb Pharma Sa |
Therapeutic agents
|
|
EP3738605A1
(en)
|
2012-09-10 |
2020-11-18 |
Xencor, Inc. |
Methods of treating neurological diseases
|
|
KR101759687B1
(ko)
|
2013-01-25 |
2017-07-19 |
타이몬, 엘엘씨 |
순환하는 생물활성 가용성 tnf의 선택적 감소를 위한 조성물 및 tnf-매개 질환의 치료 방법
|
|
MX2015012138A
(es)
|
2013-03-12 |
2016-06-02 |
Anellotech Inc |
Regeneracion de catalizador de pirolisis rapida catalitica.
|
|
JP2016527225A
(ja)
|
2013-07-15 |
2016-09-08 |
ノヴォ ノルディスク アー／エス |
ウロキナーゼ型プラスミノーゲン活性化因子に結合する抗体
|
|
GB201321738D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
GB201321739D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321744D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321729D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
ES2809535T3
(es)
|
2013-12-09 |
2021-03-04 |
UCB Biopharma SRL |
Derivados de imidazopiridina como moduladores de la actividad de TNF
|
|
GB201321734D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
GB201321748D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321740D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321741D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321733D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321746D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321737D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
GB201321736D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321728D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
WO2015086523A1
(en)
|
2013-12-09 |
2015-06-18 |
Ucb Biopharma Sprl |
Fused bicyclic heteroaromatic derivatives as modulators of tnf activity
|
|
GB201321743D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321742D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321732D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321731D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321749D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321745D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321730D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
GB201321735D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
TN2017000083A1
(en)
|
2014-10-03 |
2018-07-04 |
Sanofi Sa |
Fused pentacyclic imidazole derivatives
|
|
CA2975376A1
(en)
|
2015-01-30 |
2016-08-04 |
Saitama Medical University |
Anti-alk2 antibody
|
|
CA2980159A1
(en)
|
2015-03-18 |
2016-09-22 |
Bristol-Myers Squibb Company |
Substituted tricyclic heterocyclic compounds
|
|
KR102630010B1
(ko)
|
2015-03-18 |
2024-01-25 |
브리스톨-마이어스 스큅 컴퍼니 |
Tnf의 억제제로서 유용한 트리시클릭 헤테로시클릭 화합물
|
|
KR102696304B1
(ko)
|
2015-03-18 |
2024-08-16 |
브리스톨-마이어스 스큅 컴퍼니 |
Tnf의 억제제로서 유용한 헤테로시클릭 화합물
|
|
WO2016168638A1
(en)
|
2015-04-17 |
2016-10-20 |
Abbvie Inc. |
Indazolones as modulators of tnf signaling
|
|
WO2016168641A1
(en)
|
2015-04-17 |
2016-10-20 |
Abbvie Inc. |
Tricyclic modulators of tnf signaling
|
|
UY36629A
(es)
|
2015-04-17 |
2016-11-30 |
Abbvie Inc |
Indazolonas como moduladores de la señalización de tnf
|
|
GB201509885D0
(en)
|
2015-06-08 |
2015-07-22 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
GB201509893D0
(en)
|
2015-06-08 |
2015-07-22 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
GB201509888D0
(en)
|
2015-06-08 |
2015-07-22 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
GB201510758D0
(en)
|
2015-06-18 |
2015-08-05 |
Ucb Biopharma Sprl |
Novel TNFa structure for use in therapy
|
|
CA2994703A1
(en)
|
2015-08-03 |
2017-02-09 |
Bristol-Myers Squibb Company |
Cyclic compounds useful as modulators of tnf alpha
|
|
EP3331871A1
(en)
|
2015-08-03 |
2018-06-13 |
Bristol-Myers Squibb Company |
Heterocyclic compounds useful as modulators of tnf alpha
|
|
EP3436456B1
(en)
|
2016-04-01 |
2021-11-17 |
UCB Biopharma SRL |
Fused hexacyclic imidazole derivatives as modulators of tnf activity
|
|
EP3436459B1
(en)
|
2016-04-01 |
2021-08-25 |
UCB Biopharma SRL |
Fused pentacyclic imidazole derivatives as modulators of tnf activity
|
|
US10793578B2
(en)
|
2016-04-01 |
2020-10-06 |
UCB Biopharma SRL |
Fused pentacyclic imidazole derivatives as modulators of TNF activity
|
|
EA201892142A1
(ru)
|
2016-04-01 |
2019-04-30 |
Юсб Байофарма Спрл |
Конденсированные пентациклические производные имидазола в качестве модуляторов активности tnf
|
|
GB201621907D0
(en)
|
2016-12-21 |
2017-02-01 |
Ucb Biopharma Sprl And Sanofi |
Antibody epitope
|